Re-biopsy from bone metastatis lessio... - Advanced Prostate...

Advanced Prostate Cancer

21,603 members27,047 posts

Re-biopsy from bone metastatis lessions ? Will it pass proper DNA quality check for BRCA/HRR testing ??

pka21 profile image
5 Replies

We had our recent PSMA PET SCAN on 19th Mar, Dr. suggested to do re biospy this time to find out any treatable mutation since in last scan we did not get any feasible site. (Majority of standard care got failed/used)

Since nothing is in Prostate, my MO said its generally difficult to do biospy from bone lessions as per our scan and sometime we did not get proper DNA quality for testing, But for checking feasibility, Reffered to IR Dr. Who said they can do it.

But Nobody is giving any confidence that we will be benefitted from this and also my father is little scared of re biospy.

Can someone pls share their experience or thoughts on this?

Written by
pka21 profile image
pka21
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Tall_Allen profile image
Tall_Allen

Even if there is no tailored therapy yet, there may be some in clinical trials.

pka21 profile image
pka21 in reply to Tall_Allen

Thanks TA for the response!

MO planned to start Honovan and Nuclear Med Dr. gaved the option for Ac225 as further lu177 is not going to be benefitted.

For Ac225 also, waiting period is more than a month for med availability and it is costly as well.

Also Not sure how it will work after lu177 got failed , considering patient has many psma avid and many psma non avid sites present on psma pet scan.

Can Ac225 work in our case ?

Regarding clinical trail, As per Dr, there is no clinical trail going on in TMH and not sure about other places in India. Request ur help if you have any info on this please.

Tall_Allen profile image
Tall_Allen in reply to pka21

I think PSMA-targeted radiotherapy is dangerous in men with discordant cancers. Some disagree.

prostatecancer.news/2019/12...

MateoBeach profile image
MateoBeach in reply to pka21

What does Ishita Sen say?

ishitasen profile image
ishitasen in reply to pka21

We have treated a number of patients with Ac225 following failure with lu177. There is usually a fairly good response with a median duration of progression free survival in bone only disease of about 8 - 9 months. The problem with Ac225 is the salivary gland toxicity and the cost. Also to some extent the availability. The Ac225 supply chain will likely improve after about 6 months, till then supply is extremely restricted

Not what you're looking for?

You may also like...

Cabazitaxel not working anymore seems, PSMA Scan & PSA shows progression

now. went for PSMA PET CT on 17th Aug: In comparison to previous 68Ga PSMA PET-CT scan dated...

Primary Care Dr stated \"google Doctoring on web sites\"

in regards to the spinal scan and bone scan as well as CT scan not showing any Mets to bones(...

Elgie New Doctor Referral

approve the better scans, new testing, etc. and not try and tell us that the pet scan is better...

Alternate Cure for Cancer Dr Matthias Rath Cellular Solutions

nameless9999 ) I believe I am been insensitive and did not know he has been depressed of late. In...

Which scan(s) and how do we ask?

scheduled the scans, but I am confused as to why a bone scan would be ordered instead of a PET scan...